홈 > 시장보고서 > 의약품 > 파이프라인 분석

시장보고서

상품코드

1741437

모기 매개 질병 시장 : 질환 유형별, 치료 유형별, 최종 사용자별, 지역별

Mosquito Borne Disease Market, By Disease Type, By Treatment Type, By End User, By Geography

발행일: 2025년 03월 | 리서치사:

Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

모기 매개 질병 시장은 2025년에는 35억 8,000만 달러로 추정되고, 2032년에는 58억 6,000만 달러에 이를 전망이며, 2025-2032년 연평균 성장률(CAGR) 7.3%로 성장이 예측되고 있습니다.

보고 범위		보고서 세부정보
기준 연도	2024년	시장 규모(2025년)	35억 8,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간 CAGR(2025-2032년) :	7.30%	예측 금액(2032년)	58억 6,000만 달러

모기 매개 질병은 세계 각지에서 공중 보건에 심각한 문제가 되고 있습니다. 감염된 모기에 물림으로써 감염되는 이러한 질병은 인간의 생명을 위협하고 상당한 질병 부담의 원인이 되고 있습니다. 모기 매개 질병과 싸우기 위한 혁신적인 해결책 중 하나가 모기를 가까이 하지 않는 석판 개발입니다. 이 석판은 모기에 대한 효과적인 장벽 역할을 하며 말라리아, 뎅기열, 지카 바이러스 등의 질병의 위험을 줄여줍니다.

시장 역학 :

세계의 모기 매개 질병 시장은 모기 매개 질병의 발생률이 증가하고 공중 보건에 미치는 영향에 대한 의식이 증가함에 따라 가까운 미래에 큰 성장이 예상됩니다. 정부와 의료기관은 효과적인 진단법과 치료법을 개발하기 위해 연구개발에 많은 투자를 하고 있습니다. 살충제나 모기퇴치기 같은 모기 구제 방법에 대한 기술의 진보가 시장 성장에 더욱 공헌하고 있습니다. 그러나 대처해야 할 과제도 몇 가지 있습니다. 시장 성장의 주요 억제 요인 중 하나는 특히 신흥 국가에서 의료 시설에 대한 인식과 접근성이 부족하다는 것입니다. 제한된 의료 인프라, 불충분한 자금, 열악한 위생 환경이 모기 매개 질병의 만연을 조장하고 있습니다. 게다가 모기의 약제 내성 개발과 백신 개발의 복잡성은 시장에 있어서 큰 과제가 되고 있습니다.

이러한 과제에도 불구하고 세계의 모기 매개 질병 시장에는 큰 기회가 있습니다. 새로운 진단 도구, 치료제, 백신의 개발은 잠재적인 성장 전망을 제공합니다. 아울러 제약회사, 연구기관, 정부 간 협력과 제휴로 모기 구제 및 예방을 위한 혁신적인 솔루션 개발이 가속화될 것으로 보입니다.

본 조사의 주요 특징

본 보고서에서는 세계의 모기 매개 질병 시장을 상세하게 분석하고, 2024년을 기준연도로 한 예측 기간(2025-2032년) 시장 규모 및 연간 평균 성장률(CAGR%)을 제공합니다.
또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
세계의 모기 매개 질병 시장에서 주요 기업 프로파일을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등의 파라미터에 근거해 제공합니다.
본 보고서의 인사이트를 통해 마케팅 담당자 및 기업의 경영진은 장래의 제품 발매, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
세계의 모기 매개 질병 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자에 대응하고 있습니다.
이해관계자는 세계 모기 매개 질병 시장의 분석에 사용되는 다양한 전략 매트릭스를 통해, 의사 결정을 용이하게 할 수 있습니다.

GlaxoSmithKline plc
Sanofi SA
Pfizer Inc.
Merck & Co., Inc.
Novartis AG
Johnson & Johnson
Eisai Co., Ltd
Takeda Pharmaceutical Company Limited
AstraZeneca
Valeant Pharmaceuticals International, Inc.
Mitsubishi Tanabe Pharma Corporation
Abbott
Hoffmann-La Roche Ltd
Sun Pharmaceutical Industries Ltd
Lupin Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
Serum Institute of India Pvt. Ltd.
CSL Limited
Teva Pharmaceutical Industries Ltd

제10장 섹션

조사 방법
출판사에 대해

AJY 25.06.16

Mosquito Borne Disease Market is estimated to be valued at USD 3.58 Bn in 2025 and is expected to reach USD 5.86 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 3.58 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.30%	2032 Value Projection:	USD 5.86 Bn

Mosquito borne disease have been a significant public health concern in several parts of the world. These diseases, transmitted through the bite of infected mosquitoes, pose a threat to human lives, and are responsible for a considerable disease burden. One innovative solution to combat mosquito borne diseases is the development of a stone slab that repels mosquitoes, and thus, offering protection to individuals. This stone slab acts as an effective barrier against mosquitoes, reducing the risk of diseases such as malaria, dengue fever, and Zika virus.

Market Dynamics:

Global mosquito borne disease market is expected to witness significant growth in the near future due to increasing incidence of mosquito-borne diseases, coupled with growing awareness about their impact on public health. Governments and healthcare organizations are investing heavily in research and development to develop effective diagnostics and treatment options. Technological advancements in mosquito control methods such as insecticides and mosquito traps are further contributing to market growth. However, there are also several challenges that need to be addressed. One of the major restraints for the market growth is the lack of awareness and access to healthcare facilities, particularly in developing countries. Limited healthcare infrastructure, inadequate funding, and poor sanitation contribute to the spread of mosquito-borne diseases. Furthermore, the development of drug resistance in mosquitoes and the complexity of vaccine development pose significant challenges to the market.

Despite these challenges, there are significant opportunities in the global mosquito borne disease market. The development of new diagnostic tools, therapeutic drugs, and vaccines offers potential growth prospects. Moreover, collaborations and partnerships between pharmaceutical companies, research institutions, and governments are likely to accelerate the development of innovative solutions for mosquito control and prevention.

Key features of the study:

This report provides in-depth analysis of the global mosquito borne disease market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global mosquito borne disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson, Eisai Co., Ltd, Takeda Pharmaceutical Company Limited, AstraZeneca, Valeant Pharmaceuticals International, Inc., Mitsubishi Tanabe Pharma Corporation, Abbott , F. Hoffmann-La Roche Ltd, Sun Pharmaceutical Industries Ltd, Lupin Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Serum Institute of India Pvt. Ltd., CSL Limited, and Teva Pharmaceutical Industries Ltd
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global mosquito borne disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mosquito borne disease market

Mosquito Borne Disease Market Detailed Segmentation:

By Disease Type:
- Malaria
- Dengue
- Yellow Fever
- West Nile Virus
- Chikungunya
- Zika Virus
- Others
By Treatment Type:
- Medication
- Vaccination
- Vector Control Methods
- Immunotherapy
- Supportive Care
- Others
By End User:
- Hospitals
- Clinics
- Diagnostic Centers
- Research Institutes
- Government Organizations
- NGOs
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- GlaxoSmithKline plc
- Sanofi S.A.
- Pfizer Inc.
- Merck & Co., Inc.
- Novartis AG
- Johnson & Johnson
- Eisai Co., Ltd
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Valeant Pharmaceuticals International, Inc.
- Mitsubishi Tanabe Pharma Corporation
- Abbott
- F.Hoffmann-La Roche Ltd
- Sun Pharmaceutical Industries Ltd
- Lupin Pharmaceuticals, Inc.
- BioCryst Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Serum Institute of India Pvt. Ltd.
- CSL Limited
- Teva Pharmaceutical Industries Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Mosquito Borne Disease, By Disease Type
- Market Mosquito Borne Disease, By Treatment Type
- Market Mosquito Borne Disease, By End User
- Market Mosquito Borne Disease, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Mosquito Borne Disease Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Mosquito Borne Disease Market, By Disease Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Malaria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Dengue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Yellow Fever
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
West Nile Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Chikungunya
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Zika Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Mosquito Borne Disease Market, By Treatment Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Vaccination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Vector Control Methods
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bin)
Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Supportive Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Mosquito Borne Disease Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Government Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
NGOs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Mosquito Borne Disease Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eisai Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Valeant Pharmaceuticals International, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mitsubishi Tanabe Pharma Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sun Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lupin Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BioCryst Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Serum Institute of India Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
CSL Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,500

￦ 6,676,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 7,000

￦ 10,385,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,837,000

※ 부가세 별도

모기 매개 질병 시장 : 질환 유형별, 치료 유형별, 최종 사용자별, 지역별

Mosquito Borne Disease Market, By Disease Type, By Treatment Type, By End User, By Geography

시장 역학 :

본 조사의 주요 특징

목차

제1장 조사의 목적 및 전제조건

제2장 시장 전망

제3장 시장 역학, 규제 및 동향 분석

제4장 세계의 모기 매개 질병 시장 : 코로나 바이러스(COVID-19) 팬데믹의 영향

제5장 세계의 모기 매개 질병 시장 : 질환 유형별(2020-2032년)

제6장 세계의 모기 매개 질병 시장 : 치료 유형별(2020-2032년)

제7장 세계의 모기 매개 질병 시장 : 최종 사용자별(2020-2032년)

제8장 세계의 모기 매개 질병 시장 : 지역별(2020-2032년)

제9장 경쟁 구도